Waters Parkerson & Co. acquired 462 shares of Vertex Pharmaceuticals in Q2, joining other hedge funds increasing their stakes.
Waters Parkerson & Co. LLC acquired 462 shares of Vertex Pharmaceuticals (NASDAQ:VRTX) worth about $217,000 in Q2, joining multiple hedge funds that have increased their stakes. Institutional investors own 90.96% of the company. Recently, insiders sold shares, and analysts provided varied ratings, with a consensus "Hold" and a price target of $486.36. VRTX shares opened at $464.92, with a market cap of $119.97 billion and a 52-week range of $341.85 to $510.64.
September 21, 2024
8 Articles